Literature DB >> 17955494

The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell.

Zvi Bar-Shavit1.   

Abstract

Osteoclasts are multinucleated cells that derive from hematopoietic progenitors in the bone marrow which also give rise to monocytes in peripheral blood, and to the various types of tissue macrophages. Osteoclasts are formed by the fusion of precursor cells. They function in bone resorption and are therefore critical for normal skeletal development (growth and modeling), for the maintenance of its integrity throughout life, and for calcium metabolism (remodeling). To resorb bone, the osteoclasts attach to the bone matrix, their cytoskeleton reorganizes, and they assume polarized morphology and form ruffled borders to secrete acid and collagenolytic enzymes and a sealing zone to isolate the resorption site. Identification of the osteoclastogenesis inducer, the receptor activator of nuclear factor-kappaB ligand (RANKL), its cognate receptor RANK, and its decoy receptor osteoprotegerin (OPG), has contributed enormously to the dramatic advance in our understanding of the molecular mechanisms involved in osteoclast differentiation and activity. This explosion in osteoclast biology is reflected by the large number of reviews which appeared during the last decade. Here I will summarize the "classical" issues (origin, differentiation, and activity) in a general manner, and will discuss an untouched issue (multinucleation) and a relatively novel aspect of osteoclast biology (osteoimmunology). (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17955494     DOI: 10.1002/jcb.21553

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  89 in total

1.  Diabetes impairs the interactions between long-term hematopoietic stem cells and osteopontin-positive cells in the endosteal niche of mouse bone marrow.

Authors:  Hironori Chiba; Koji Ataka; Kousuke Iba; Kanna Nagaishi; Toshihiko Yamashita; Mineko Fujimiya
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-24       Impact factor: 4.249

Review 2.  The Histochemistry and Cell Biology omnium-gatherum: the year 2015 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2016-02-15       Impact factor: 4.304

3.  Macrophage cathepsin K promotes prostate tumor progression in bone.

Authors:  M K Herroon; E Rajagurubandara; D L Rudy; A Chalasani; A L Hardaway; I Podgorski
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

4.  DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Authors:  W Wisitrasameewong; M Kajiya; A Movila; S Rittling; T Ishii; M Suzuki; S Matsuda; Y Mazda; M R Torruella; M M Azuma; K Egashira; M O Freire; H Sasaki; C Y Wang; X Han; M A Taubman; T Kawai
Journal:  J Dent Res       Date:  2017-02-15       Impact factor: 6.116

5.  Thy1 is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice.

Authors:  Ananta Paine; Collynn F Woeller; Hengwei Zhang; Maria de la Luz Garcia-Hernandez; Nelson Huertas; Lianping Xing; Richard P Phipps; Christopher T Ritchlin
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

6.  Protein kinase D promotes in vitro osteoclast differentiation and fusion.

Authors:  Kim C Mansky; Eric D Jensen; Julia Davidova; Masato Yamamoto; Rajaram Gopalakrishnan
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

7.  CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.

Authors:  Hernan Roca; Zachary S Varsos; Kenneth J Pienta
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 8.  [Pathophysiology of bone metabolism].

Authors:  F Jakob; L Seefried; R Ebert
Journal:  Internist (Berl)       Date:  2008-10       Impact factor: 0.743

9.  Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.

Authors:  Aditya Parekh; Subhayan Das; Sheetal Parida; Chandan Kanta Das; Debabrata Dutta; Sanjaya K Mallick; Pei-Hsun Wu; B N Prashanth Kumar; Rashmi Bharti; Goutam Dey; Kacoli Banerjee; Shashi Rajput; Deblina Bharadwaj; Ipsita Pal; Kaushik Kumar Dey; Yetirajam Rajesh; Bikash Chandra Jena; Angana Biswas; Payel Banik; Anjan K Pradhan; Swadesh K Das; Amit Kumar Das; Santanu Dhara; Paul B Fisher; Denis Wirtz; Gordon B Mills; Mahitosh Mandal
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

10.  Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis.

Authors:  Sylvain Marcellini; Carola Bruna; Juan P Henríquez; Miguel Albistur; Ariel E Reyes; Elias H Barriga; Berta Henríquez; Martín Montecino
Journal:  BMC Evol Biol       Date:  2010-03-17       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.